Cytokinetics | CYTK - Заемный капитал





Заемный капитал Изменить Дата
Acadia Pharmaceuticals USD 0 0 2025-03
Amgen USD 50B 2.43B 2025-12
Bayer EUR 31.83B 877M 2025-12
Biogen USD 6.29B 1.4M 2025-09
Brainstorm Cell Therapeutics USD 0 0 2025-03
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Capricor Therapeutics USD 3.38M 0 2025-03
Cytokinetics USD 1.12B 957.23M 2025-12
Eisai JPY 134.77B 12M 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
Geron USD 119.55M 283K 2025-12
Halozyme Therapeutics USD 2.14B 1.34B 2025-12
Ionis Pharmaceuticals USD 1.9B 1.87B 2025-12
Ligand Pharmaceuticals USD 445.49M 445.44M 2025-09
Merck USD 39.97B 6B 2025-09
Novartis USD 29.59B 5.35B 2025-12
Pfizer USD 57.41B 93M 2025-09
Regeneron Pharmaceuticals USD 1.99B 719.7M 2026-03
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 13.84B 1.88B 2026-03